Investigators have launched a 3-year study to develop predictive models that will help identify better treatment plans for patients with depression.
News
We must not allow what happened at the Alamo to happen to Ukraine.
Psychiatric Times featured a wide variety of psychiatric issues and current events throughout February.
The experts weighed in on a wide variety of psychiatric issues for the Psychiatric Times February 2022 issue.
A psychiatrist's thoughts and reflections after the week's news.
The Trust renews its commitment to the field of psychoanalysis with this new appointment.
“Most people say that pretty much all physicians have a book inside them—and I agree.”
Digital therapeutics may be poised to step up as the next CBT.
Mental health providers advocate for others—but what about for themselves?
Respondents discussed COVID-19 conditions and mental health benefits.
Mixed results from recent study of health care workers. What does it all mean?
How can psychopharmacologists effectively (and safely) prescribe stimulants to patients with ADHD who may be using psychoactive substances?
New book explores the effects of modern life and technology on mental illness.
The Ukrainian invasion has begun. What does this say of Putin?
Panelists presented 2 studies comparing evidence-based strategies for improved patient outcomes.
The average patient with bipolar disorder struggles with sleep disorders. Here's how you can help.
The state of US mental health may be poor, but what about psychiatrists specifically?
Comorbidity: The concept is simple enough, but in practice, comorbidity drives complexity and presents the specters of diagnostic ambiguity and therapeutic unpredictability.
Brain Capital: An Emerging Investment Opportunity
ByHarris A. Eyre, MD, PhD,Mark Faulkenberg,Sanjiv Das,James T. Hackett,Shuo Chen, JD,Francois Véron,Pawel Swieboda,Geoffrey S.F. Ling, MD, PhD,Eric W. Bennett,Shekhar Saxena, MD,Steve Carnevale,Ethan Powell,Erin Smith,Agustin Ibañez, PhD,Stephen T. Wong, PhD,Eric A. Storch, PhD,Evelyn Chan, MBBS, MSc,Mark Heinemeyer,Ian Robertson, PhD,Walter D. Dawson, DPhil,Dapo Tomori, MD,Jair C. Soares, MD,Ryan Abbott, MD, JD, PhD,Sebastian F. Winter, MD,Sandra Bond Chapman, PhD,Anastasia Budinskaya, MSc,Lisa Brown, PhD,Lynne Corner, PhD,Kirk Nylen, PhD,Garth Smith, PhD,Tom Mikkelsen, MD,Michael Berk, MD, PhD
Brain Capital: a fresh approach to technologies and investing.
If approved, this will be the fourth indication for the drug, joining its approvals for episodes associated with bipolar I disorder and schizophrenia.
Surviving is harder than it looks…
Here’s how to help patients—and ourselves—recognize cognitive distortions.
Catch up on all the latest in ADHD from the APSARD virtual 2022 Annual Meeting.
When therapists are terminally ill, should they err on the side of self-disclosure or silence?
Is the US doing a worse job at caring for its citizens mental health than countries like the Netherlands?
Child custody battles can get contentious. Here’s how to handle false allegations.
Presidents Day may be a good signifier of the changing times.
The Commission on Combating Synthetic Opioid Trafficking shared startling data as well as suggestions to combat what it calls a "national crisis."
Evaluating a new framework for evaluating undue influence and its implications for elder abuse and human trafficking cases.
Apetamin has been promoted worldwide as a weight gain supplement—but what are the dangers of misuse?
Advertisement
Advertisement
Trending on Psychiatric Times
1
Extension of Expanded Access Program for Zervimesine to Treat Dementia With Lewy Bodies
2
A New Era of Mental Health: Increasing Youth Access to the 988 Lifeline and Campus Suicide Prevention
3
Increasing Prevalence of Long-Term Antidepressant Use in Australia: A Retrospective Observational Study
4
Why Global Integration Is Essential for the Future of DSM
5